December 26, 2018
Fuji Yakuhin has field a new drug application in Japan for its investigational gout and hyperuricemia treatment dotinurad, also known as FYU-981, the company and its partner Mochida Pharmaceutical said on December 25. Originated by Fuji Yakuhin, dotinurad reduces blood...read more